The parents of Cole Schmidtknecht are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the 22-year-old ...

Cory Schmidtknecht's family is demanding damages from Walgreens Pharmacy and United Health Group's OptumRx for their alleged ...

Access to affordable healthcare and prescription drugs is an ongoing problem that affects a significant number of the ...

A Wisconsin man reportedly passed away in extreme agony after the price of his inhaler shot skyrocketed from $67 to $540, and ...

Cole Schmidtknecht had chronic asthma since he was a child, and had used a steroid inhaler to control his symptoms for more ...

Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...

Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result in increased acute care utilization and costs, which ...

As of October 2022, Vascepa had coverage without restrictions for more than 90% of Medicare Part D enrollees, according to its manufacturer. According to Optum Perks, 30 capsules of Vascepa cost as ...

It's no secret that Americans are frustrated with what they're paying for prescription drugs. Most people blame drug ...

Pharmacy benefit managers, commonly referred to as PBMs ... “That’s when CVS Caremark fueled increased competition by ...